Swiss - Delayed Quote CHF

Addex Therapeutics Ltd (ADXN.SW)

0.0614
+0.0010
+(1.66%)
At close: June 13 at 5:31:20 PM GMT+2
Currency in CHF All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
404.1020
404.1020
1,612.9530
1,422.4380
2,916.3080
Operating Expense
3,159.3350
3,159.3350
3,855.9200
11,963.3390
18,422.2220
Operating Income
-2,755.2330
-2,755.2330
-2,242.9670
-10,540.9010
-15,505.9140
Net Non Operating Interest Income Expense
5.6180
5.6180
60.0990
1.3050
-57.6900
Other Income Expense
-2,159.7270
-2,159.7270
-317.2850
-264.3600
211.6930
Pretax Income
-4,909.3420
-4,909.3420
-2,500.1530
-10,803.9560
-15,351.9140
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
7,055.7870
7,055.7870
-10,556.2270
-20,804.2130
-15,351.9140
Diluted NI Available to Com Stockholders
7,055.7870
7,055.7870
-10,556.2270
-20,804.2130
-15,351.9140
Basic EPS
0.07
--
-0.14
-0.46
-0.45
Diluted EPS
0.07
--
-0.14
-0.46
-0.45
Basic Average Shares
98,112.8260
--
74,307.6350
45,184.8650
34,119.6660
Diluted Average Shares
167,655.8270
--
148,130.5550
82,235.9900
34,119.6660
Total Operating Income as Reported
-2,755.2330
-2,755.2330
-2,242.9670
-10,540.9010
-15,505.9170
Rent Expense Supplemental
--
--
35.5670
47.2830
37.5120
Total Expenses
3,159.3350
3,159.3350
3,855.9200
11,963.3390
18,422.2220
Net Income from Continuing & Discontinued Operation
7,055.7870
7,055.7870
-10,556.2270
-20,804.2130
-15,351.9140
Normalized Income
-4,926.7720
-4,926.7720
-2,182.8680
-10,539.5960
-15,563.6070
Interest Income
9.1650
9.1650
63.9640
29.2510
5.3220
Interest Expense
3.5470
3.5470
3.8650
27.9460
63.0120
Net Interest Income
5.6180
5.6180
60.0990
1.3050
-57.6900
EBIT
-4,905.7950
-4,905.7950
-2,496.2880
-10,776.0100
-15,288.9020
EBITDA
-4,645.6750
-4,645.6750
-2,190.3360
-10,452.8660
-14,941.2890
Reconciled Depreciation
260.1200
260.1200
305.9520
323.1440
347.6130
Net Income from Continuing Operation Net Minority Interest
-4,909.3420
-4,909.3420
-2,500.1530
-10,803.9560
-15,351.9140
Total Unusual Items Excluding Goodwill
17.4300
17.4300
-317.2850
-264.3600
211.6930
Total Unusual Items
17.4300
17.4300
-317.2850
-264.3600
211.6930
Normalized EBITDA
-4,663.1050
-4,663.1050
-1,873.0510
-10,188.5060
-15,152.9820
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/22/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

0M4.BE Mersana Therapeutics Inc
0.3149
+1.55%
 
SPAGO.ST Spago Nanomedical AB (publ)
0.2000
-6.54%
 
BIOV.SW BioVersys AG
35.10
0.00%
 
EVE.SW Evolva Holding SA
1.1200
+1.82%
 
MOLN.SW Molecular Partners AG
3.1150
-0.80%
 
22UA.HM BioNTech SE
92.15
+1.38%
 
OBIO Orchestra BioMed Holdings, Inc.
3.0900
-2.22%
 
RLF.SW Relief Therapeutics Holding SA
2.2700
+0.22%
 
IDIA.SW Idorsia Ltd
2.0300
-2.17%
 
5CV.DE CureVac N.V.
4.7780
-2.49%